Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotransmitter reuptake inhibitors in mental and physical fatigue
2022-002836-30Phase 4Active
- Sponsor
- Vrije Universiteit Brussel
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of citalopram, reboxetine and methylphenidate (4 arms), sponsored by Vrije Universiteit Brussel. Primary endpoint: Study completion after four sessions. Started Dec 2022; status: active.
02
Drugs
citalopramreboxetinemethylphenidate
Beyond the preview
Go deeper on 2022-002836-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002836-30.